Clinical approach to vasoplegia in the transplant patient from the Pediatric Heart Transplant Society
Shriprasad R. Deshpande
Department of Cardiology and Cardiovascular Surgery, Children's National Hospital, The George Washington University, Washington, DC, USA
Search for more papers by this authorDavid W. Bearl
Department of Pediatric Cardiology, Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA
Search for more papers by this authorPirooz Eghtesady
Section of Pediatric Cardiothoracic Surgery, St Louis Children's Hospital and School of Medicine, Washington University, St Louis, Michigan, USA
Search for more papers by this authorHeather T. Henderson
Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
Search for more papers by this authorScott Auerbach
Pediatrics, Division of Cardiology, University of Colorado, Denver Anschutz Medical Campus, Children's Hospital Colorado Aurora, Aurora, Colorado, USA
Search for more papers by this authorAamir Jeewa
Department of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada
Search for more papers by this authorNeha Bansal
Children's Hospital at Montefiore, Bronx, New York, USA
Search for more papers by this authorShahnawaz Amdani
Cleveland Clinic Children's, Cleveland, Ohio, USA
Search for more papers by this authorMarc E. Richmond
Division of Pediatric Cardiology, Department of Pediatrics, Columbia University College of Physician and Surgeons, Morgan Stanley Children's Hospital, New York, New York, USA
Search for more papers by this authorLoren D. Sacks
Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, California, USA
Search for more papers by this authorRenata Shih
Congenital Heart Center, Division of Pediatric Cardiology, University of Florida, Gainesville, Florida, USA
Search for more papers by this authorMadeleine Townsend
Cleveland Clinic Children's, Cleveland, Ohio, USA
Search for more papers by this authorCorresponding Author
Jennifer Conway
Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada
Correspondence
Jennifer Conway, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
Email: [email protected]
Search for more papers by this authorShriprasad R. Deshpande
Department of Cardiology and Cardiovascular Surgery, Children's National Hospital, The George Washington University, Washington, DC, USA
Search for more papers by this authorDavid W. Bearl
Department of Pediatric Cardiology, Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA
Search for more papers by this authorPirooz Eghtesady
Section of Pediatric Cardiothoracic Surgery, St Louis Children's Hospital and School of Medicine, Washington University, St Louis, Michigan, USA
Search for more papers by this authorHeather T. Henderson
Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA
Search for more papers by this authorScott Auerbach
Pediatrics, Division of Cardiology, University of Colorado, Denver Anschutz Medical Campus, Children's Hospital Colorado Aurora, Aurora, Colorado, USA
Search for more papers by this authorAamir Jeewa
Department of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada
Search for more papers by this authorNeha Bansal
Children's Hospital at Montefiore, Bronx, New York, USA
Search for more papers by this authorShahnawaz Amdani
Cleveland Clinic Children's, Cleveland, Ohio, USA
Search for more papers by this authorMarc E. Richmond
Division of Pediatric Cardiology, Department of Pediatrics, Columbia University College of Physician and Surgeons, Morgan Stanley Children's Hospital, New York, New York, USA
Search for more papers by this authorLoren D. Sacks
Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, California, USA
Search for more papers by this authorRenata Shih
Congenital Heart Center, Division of Pediatric Cardiology, University of Florida, Gainesville, Florida, USA
Search for more papers by this authorMadeleine Townsend
Cleveland Clinic Children's, Cleveland, Ohio, USA
Search for more papers by this authorCorresponding Author
Jennifer Conway
Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada
Correspondence
Jennifer Conway, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
Email: [email protected]
Search for more papers by this authorAbstract
This manuscript outlines a clinical approach to vasoplegia incorporating the current state of knowledge regarding vasoplegia in pediatric patients immediately post-transplant and to identify modifiable factors both pre- and post-transplant that may reduce post-operative morbidity, end-organ dysfunction, and mortality. Centers participating in the Pediatric Heart Transplant Society (PHTS) were asked to provide their internal protocols and rationale for vasoplegia management, and applicable adult and pediatric data were reviewed. The authors synthesized the above protocols and literature into the following description of clinical approaches to vasoplegia highlighting areas of both broad consensus and of significant practice variation.
CONFLICT OF INTEREST
All authors have no relevant conflicts of interest.
Open Research
DATA AVAILABILITY STATEMENT
Data for the manuscript can be found in the sited peer-reviewed articles.
REFERENCES
- 1Chan JL, Kobashigawa JA, Aintablian TL, et al. Characterizing predictors and severity of vasoplegia syndrome after heart transplantation. Ann Thorac Surg. 2018; 105: 770-777.
- 2Sacks LD, Hollander SA, Zhang Y, et al. Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device. J Thorac Cardiovasc Surg. 2019; 157: 2433-2440.
- 3Byrne JG, Leacche M, Paul S, et al. Risk factors and outcomes for ‘vasoplegia syndrome’ following cardiac transplantation. Eur J Cardiothorac Surg. 2004; 25: 327-332.
- 4Asleh R, Alnsasra H, Daly RC, et al. Predictors and clinical outcomes of vasoplegia in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. J Am Heart Assoc. 2019; 8:e013108.
- 5Patarroyo M, Simbaqueba C, Shrestha K, et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant. 2012; 31: 282-287.
- 6Raza FS, Lee AY, Jamil AK, et al. Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation. Am J Cardiol. 2018; 122: 1902-1908.
- 7Pandya NR, Alphonso N, Tu Q, Venugopal P, Schlapbach LJ. Prolonged postoperative vasoplegia in pediatric patients on chronic angiotensin II blocker treatment. Front Cardiovasc Med. 2018; 5: 121.
- 8Dayan V, Cal R, Giangrossi F. Risk factors for vasoplegia after cardiac surgery: a meta-analysis. Interact Cardiovasc Thorac Surg. 2019; 28: 838-844.
- 9Chan JL, Kobashigawa JA, Aintablian TL, et al. Vasoplegia after heart transplantation: outcomes at 1 year. Interact Cardiovasc Thorac Surg. 2017; 25: 212-217.
- 10Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg. 2010; 22: 140-144.
- 11Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015; 349: 80-88.
- 12Gamcrlidze MM, Intskirveli NA, Vardosanidze DK, Chikhladze KE, Goliadze LS, Ratiani LR. Vasoplegia in septic shock (review). Georgian Med News. 2015; 239: 56-62.
- 13Burgdorff A-M, Bucher M, Schumann J. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms. J Int Med Res. 2018; 46: 1303-1310.
- 14Gkisioti S, Mentzelopoulos SD. Vasogenic shock physiology. Open Access Emerg Med. 2011; 3: 1-6.
- 15Wan S, Marchant A, DeSmet JM, et al. Human cytokine response to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996; 111: 469-477.
- 16Bitterman Y, Hubara E, Hadash A, Ben-Ari J, Annich G, Eytan D. Methylene blue administration for distributive shock states in critically ill children. Isr Med Assoc J. 2020; 22: 404-408.
- 17Anderson NM, Bond GY, Joffe AR, et al. The Western Canadian complex pediatric therapies program follow-up group. Post-operative fluid overload as a predictor of hospital and long-term outcomes in a pediatric heart transplant population. Pediat Transplant. 2021; 25(e13897): e13897.
- 18Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med. 1995; 23: 1907-1914.
- 19Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions of pathophysiology of vasoplegic shock. Crit Care. 2018; 22: 174.
- 20Jeon Y, Ryu JH, Lim YJ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg. 2006; 29: 952-956.
- 21Del Castillo S, Shaddy RE, Kantor PF. Update on pediatric heart failure. Curr Opin Pediatr. 2019; 31: 598-603.
- 22Rahiman S, Kowalski R, Kwok SY, et al. Milrinone acts as a vasodilator but not an inotrope in children after cardiac surgery – insights from wave intensity analysis. Crit Care Med. 2020; 48: e1071-e1078.
- 23Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options. Crit Care. 2020; 24: 36.
- 24Dünser MW, Bouvet O, Knotzer H, et al. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018; 32: 2225-2232.
- 25Egi M, Bellomo R, Langenberg C, et al. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg. 2007; 83: 715-723.
- 26Buarracino F, Habicher M, Treskatsch S, et al. Vasopressor therapy in cardiac surgery – an experts' consensus statement. J Cardiothorac Vasc Anesth. 2012; 35: 1018-1029.
- 27van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017; 136: e232-e268.
- 28Menich BE, Miano TA, Patel GP, Hammond DA. Norepinephrine and vasopressin compared with norepinephrine and epinephrine in adults with septic shock. Ann Pharmacother. 2019; 53: 877-885.
- 29Kofidis T, Strüber M, Wilhelmi M, et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg. 2001; 122: 823-824.
- 30Habib AM, Elsherbeny AG, Almehizia RA. Methylene blue for vasoplegic syndrome postcardiac surgery. Indian J Crit Care Med. 2018; 22: 168-173.
- 31Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018; 378: 809-818.
- 32Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009; 37: 666-688.
- 33Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008; 143: 1222-1226.
- 34Varvarousi G, Stefaniotou A, Varvaroussis D, Xanthos T. Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovasc Drug Ther. 2014; 28: 477-488.
- 35Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part 1): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017; 43: 1751-1763.
- 36Cios TJ, Havens B, Soleimani B, Roberts SM. Hydroxocobalamin treatment of refractory vasoplegia in patients with mechanical circulatory support. J Heart Lung Transplant. 2019; 38: 467-469.
- 37Shapeton AD, Mahmood F, Ortoleva JP. Hydroxocobalamin for the treatment of vasoplegia: a review of current literature and considerations for use. J Cardiothorac Vasc Anesth. 2019; 33: 894-901.
- 38Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin c, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017; 151: 1229-1238.
- 39Portman MA, Slee A, Olson AK, et al. Triiodothyronine supplementation in infants and children undergoing cardiopulmonary bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation. 2010; 122: S224-S233.
- 40Khanna A, English SW, Wang XS, et al. Angiotensin II for the treatment of vasodilatory shock. The N Eng J Med. 2017; 377: 419-430.
- 41Bailey DM, Chima RS, Tidmarsh GF, Williams MD. Synthetic human angiotensin II in pediatric patients with vasodilatory shock: a report on two patients. Crit Care Explor. 2019; 1: e0036.
